US Stock MarketDetailed Quotes

SPRB Spruce Biosciences

Watchlist
  • 0.464
  • -0.011-2.40%
Close Oct 1 16:00 ET
  • 0.465
  • +0.002+0.37%
Post 20:01 ET
19.14MMarket Cap-445P/E (TTM)

Spruce Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-25.64%1.61M
1.93%2M
10.09M
2.89M
3.07M
2.17M
1.96M
0
0
0
Operating revenue
-25.64%1.61M
1.93%2M
--10.09M
--2.89M
--3.07M
--2.17M
--1.96M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.83%11.65M
-3.48%14.64M
31.30%62.08M
16.03%14.05M
44.77%16.73M
35.81%16.14M
29.23%15.16M
12.40%47.28M
32.57%12.11M
1.38%11.56M
Selling and administrative expenses
18.10%3.56M
25.12%4.32M
4.68%12.65M
-9.78%2.95M
17.03%3.24M
6.70%3.01M
7.01%3.45M
6.31%12.09M
13.69%3.27M
-0.97%2.77M
-General and administrative expense
18.10%3.56M
25.12%4.32M
4.68%12.65M
-9.78%2.95M
17.03%3.24M
6.70%3.01M
7.01%3.45M
6.31%12.09M
13.69%3.27M
-0.97%2.77M
Research and development costs
-38.37%8.09M
-11.91%10.32M
40.44%49.43M
25.58%11.1M
53.50%13.49M
44.88%13.13M
37.66%11.71M
14.66%35.2M
41.24%8.84M
2.14%8.79M
Operating profit
28.17%-10.04M
4.29%-12.63M
-9.96%-51.99M
7.81%-11.16M
-18.18%-13.66M
-17.59%-13.97M
-12.49%-13.2M
-12.40%-47.28M
-32.57%-12.11M
-1.38%-11.56M
Net non-operating interest income expense
-25.52%855K
147.06%1.01M
269.36%4.07M
25.67%1.21M
735.90%1.3M
11,380.00%1.15M
1,506.90%408K
588.05%1.1M
2,071.43%966K
431.91%156K
Non-operating interest income
-26.43%938K
105.01%1.11M
199.21%4.56M
20.55%1.32M
434.96%1.42M
1,125.96%1.28M
829.31%539K
1,179.83%1.52M
2,707.69%1.1M
548.78%266K
Non-operating interest expense
-34.65%83K
-25.95%97K
15.00%483K
-17.83%106K
8.18%119K
35.11%127K
50.57%131K
21.74%420K
46.59%129K
25.00%110K
Other net income (expense)
Income before tax
28.41%-9.18M
9.12%-11.63M
-3.77%-47.92M
10.71%-9.95M
-8.36%-12.35M
-8.02%-12.82M
-8.75%-12.79M
-9.19%-46.18M
-21.34%-11.14M
0.40%-11.4M
Income tax
Net income
28.41%-9.18M
9.12%-11.63M
-3.77%-47.92M
10.71%-9.95M
-8.36%-12.35M
-8.02%-12.82M
-8.75%-12.79M
-9.19%-46.18M
-21.34%-11.14M
0.40%-11.4M
Net income continuous Operations
28.41%-9.18M
9.12%-11.63M
-3.77%-47.92M
10.71%-9.95M
-8.36%-12.35M
-8.02%-12.82M
-8.75%-12.79M
-9.19%-46.18M
-21.34%-11.14M
0.40%-11.4M
Minority interest income
Net income attributable to the parent company
28.41%-9.18M
9.12%-11.63M
-3.77%-47.92M
10.71%-9.95M
-8.36%-12.35M
-8.02%-12.82M
-8.75%-12.79M
-9.19%-46.18M
-21.34%-11.14M
0.40%-11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.41%-9.18M
9.12%-11.63M
-3.77%-47.92M
10.71%-9.95M
-8.36%-12.35M
-8.02%-12.82M
-8.75%-12.79M
-9.19%-46.18M
-21.34%-11.14M
0.40%-11.4M
Basic earnings per share
31.25%-0.22
30.00%-0.28
36.73%-1.24
51.06%-0.23
37.50%-0.3
37.25%-0.32
20.00%-0.4
-8.29%-1.96
-20.51%-0.47
2.04%-0.48
Diluted earnings per share
31.25%-0.22
30.00%-0.28
36.73%-1.24
51.06%-0.23
37.50%-0.3
37.25%-0.32
20.00%-0.4
-8.29%-1.96
-20.51%-0.47
2.04%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -25.64%1.61M1.93%2M10.09M2.89M3.07M2.17M1.96M000
Operating revenue -25.64%1.61M1.93%2M--10.09M--2.89M--3.07M--2.17M--1.96M--0--0--0
Cost of revenue
Gross profit
Operating expense -27.83%11.65M-3.48%14.64M31.30%62.08M16.03%14.05M44.77%16.73M35.81%16.14M29.23%15.16M12.40%47.28M32.57%12.11M1.38%11.56M
Selling and administrative expenses 18.10%3.56M25.12%4.32M4.68%12.65M-9.78%2.95M17.03%3.24M6.70%3.01M7.01%3.45M6.31%12.09M13.69%3.27M-0.97%2.77M
-General and administrative expense 18.10%3.56M25.12%4.32M4.68%12.65M-9.78%2.95M17.03%3.24M6.70%3.01M7.01%3.45M6.31%12.09M13.69%3.27M-0.97%2.77M
Research and development costs -38.37%8.09M-11.91%10.32M40.44%49.43M25.58%11.1M53.50%13.49M44.88%13.13M37.66%11.71M14.66%35.2M41.24%8.84M2.14%8.79M
Operating profit 28.17%-10.04M4.29%-12.63M-9.96%-51.99M7.81%-11.16M-18.18%-13.66M-17.59%-13.97M-12.49%-13.2M-12.40%-47.28M-32.57%-12.11M-1.38%-11.56M
Net non-operating interest income expense -25.52%855K147.06%1.01M269.36%4.07M25.67%1.21M735.90%1.3M11,380.00%1.15M1,506.90%408K588.05%1.1M2,071.43%966K431.91%156K
Non-operating interest income -26.43%938K105.01%1.11M199.21%4.56M20.55%1.32M434.96%1.42M1,125.96%1.28M829.31%539K1,179.83%1.52M2,707.69%1.1M548.78%266K
Non-operating interest expense -34.65%83K-25.95%97K15.00%483K-17.83%106K8.18%119K35.11%127K50.57%131K21.74%420K46.59%129K25.00%110K
Other net income (expense)
Income before tax 28.41%-9.18M9.12%-11.63M-3.77%-47.92M10.71%-9.95M-8.36%-12.35M-8.02%-12.82M-8.75%-12.79M-9.19%-46.18M-21.34%-11.14M0.40%-11.4M
Income tax
Net income 28.41%-9.18M9.12%-11.63M-3.77%-47.92M10.71%-9.95M-8.36%-12.35M-8.02%-12.82M-8.75%-12.79M-9.19%-46.18M-21.34%-11.14M0.40%-11.4M
Net income continuous Operations 28.41%-9.18M9.12%-11.63M-3.77%-47.92M10.71%-9.95M-8.36%-12.35M-8.02%-12.82M-8.75%-12.79M-9.19%-46.18M-21.34%-11.14M0.40%-11.4M
Minority interest income
Net income attributable to the parent company 28.41%-9.18M9.12%-11.63M-3.77%-47.92M10.71%-9.95M-8.36%-12.35M-8.02%-12.82M-8.75%-12.79M-9.19%-46.18M-21.34%-11.14M0.40%-11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.41%-9.18M9.12%-11.63M-3.77%-47.92M10.71%-9.95M-8.36%-12.35M-8.02%-12.82M-8.75%-12.79M-9.19%-46.18M-21.34%-11.14M0.40%-11.4M
Basic earnings per share 31.25%-0.2230.00%-0.2836.73%-1.2451.06%-0.2337.50%-0.337.25%-0.3220.00%-0.4-8.29%-1.96-20.51%-0.472.04%-0.48
Diluted earnings per share 31.25%-0.2230.00%-0.2836.73%-1.2451.06%-0.2337.50%-0.337.25%-0.3220.00%-0.4-8.29%-1.96-20.51%-0.472.04%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data